ADIPOQ and obesity disorder: Given the anti-inflammatory and vasculoprotective actions of adiponectin and the presentation of obesity as a chronic inflammatory state, the inverse association between decreased serum adiponectin levels and increased serum levels of IL-6 in our study is not surprising.